- Home
- VIAV vs APLS Comparison
VIAV vs APLS Comparison
Compare VIAV & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIAV
- APLS
- Stock Information
- Founded
- VIAV 1923
- APLS 2009
- Country
- VIAV United States
- APLS United States
- Employees
- VIAV N/A
- APLS N/A
- Industry
- VIAV Semiconductors
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- VIAV Technology
- APLS Health Care
- Exchange
- VIAV Nasdaq
- APLS Nasdaq
- Market Cap
- VIAV 2.0B
- APLS 2.3B
- IPO Year
- VIAV 1993
- APLS 2017
- Fundamental
- Price
- VIAV $9.19
- APLS $17.30
- Analyst Decision
- VIAV Buy
- APLS Buy
- Analyst Count
- VIAV 8
- APLS 19
- Target Price
- VIAV $12.69
- APLS $39.06
- AVG Volume (30 Days)
- VIAV 2.5M
- APLS 2.7M
- Earning Date
- VIAV 05-01-2025
- APLS 05-07-2025
- Dividend Yield
- VIAV N/A
- APLS N/A
- EPS Growth
- VIAV N/A
- APLS N/A
- EPS
- VIAV 0.02
- APLS N/A
- Revenue
- VIAV $1,045,800,000.00
- APLS $775,839,000.00
- Revenue This Year
- VIAV $10.56
- APLS $12.25
- Revenue Next Year
- VIAV $7.78
- APLS $21.08
- P/E Ratio
- VIAV $431.62
- APLS N/A
- Revenue Growth
- VIAV 3.34
- APLS 48.04
- 52 Week Low
- VIAV $6.60
- APLS $16.65
- 52 Week High
- VIAV $12.91
- APLS $43.99
- Technical
- Relative Strength Index (RSI)
- VIAV 34.89
- APLS 34.14
- Support Level
- VIAV $8.75
- APLS $16.65
- Resistance Level
- VIAV $9.31
- APLS $20.75
- Average True Range (ATR)
- VIAV 0.37
- APLS 1.09
- MACD
- VIAV -0.08
- APLS 0.14
- Stochastic Oscillator
- VIAV 38.38
- APLS 15.85
About VIAV Viavi Solutions Inc.
Viavi Solutions Inc. is a global provider of network test, monitoring and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of revenue from the United States.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.